| Ινστιτούτο Βιοϊατρικών Ερευνών

Programme: Research Excellence BIOMED-20
Title: "Identification of novel oncogenic protein kinases involved in lung cancer for the development of anticancer therapies"
Funding Source: Hellenic Ministry of Economy and Development
Contract Number: MIS5047236, Code: 82865
Researchers: E. Kolettas
Role: PI (WP1-4); Coordinator: S. Georgatos, University of Ioannina
Budget: 3.000.000 € (Lab: 110.000 €)
Duration: 2020 - 2023

Programme: Heracleitos
Title: "Oncogenic stress on human cells: The effects of oncogenic stress on cell proliferation, senescence, apoptosis and neoplastic transformation"
Funding Source: Hellenic Ministry of Education/EU
Contract Number: 11729
Researchers: E. Kolettas
Role: PI, Supervisor of PhD student (University of Ioannina; UoI)
Budget: 33.369 €
Duration: 2004-2006

Programme: BILATERAL SCIENTIFIC AGREEMENT BETWEEN GREECE-CYPRUS
Title: "Mechanism of action of 2-methoxyestradiol on human T leukaemic cells: The role of the anti-apoptotic gene Bcl-2 and of the transcription factor NF-?B"
Funding Source: General Secretariat of Research and Technology (GSRT), Hellenic Ministry of Development
Contract Number: 1722
Researchers: E. Kolettas
Role: PI (Greece): E. Kolettas, UoI; PI (Cyprus): A. Constantinou, Biological Sciences Dept., University o
Budget: 11.400 € (each)
Duration: 2004-2006

Programme: ARCHIMIDES II
Title: "Studies on the antioxidant properties and mechanism of action of components of Oregano vulgare L. spp. Hirtum in vitro and in vivo"
Funding Source: Hellenic Ministry of Education/EU
Contract Number: 9 (11)
Researchers: E. Kolettas
Role: PI (UoI)
Budget: 50.531 €
Duration: 2005-2008

Programme: PYTHAGORAS II
Title: "Mechanisms of action of the transcription factors E2F1 and NF-?B related to cellular senescence and apoptosis of human diploid fibroblasts"
Funding Source: Hellenic Ministry of Education/EU
Contract Number: 61/1887
Researchers: E. Kolettas
Role: PI (UoI)
Budget: 50.000 €
Duration: 2005-2008

Programme: PENED 2003
Title: "Molecular mechanisms involved in H2O2 and TNF?-induced apoptosis of tumour cells"
Funding Source: General Secretariat of Research and Technology (GSRT), Hellenic Ministry of Development
Contract Number: 2055
Researchers: E. Kolettas
Role: PI (UoI)
Budget: 180.000 € (Lab: 60.000 €)
Duration: 2006-2009

Programme: THALIS (CancerTFs), ESPA
Title: "Defining novel mechanisms whereby IKK dependent-NF-?B activation impacts on the control of E2F-target genes in normal and cancer cells‘ Secondary Title: 'Defining novel mechanisms whereby IKK-dependent NF-?B activation impacts on the control of E2F-targe
Funding Source: Hellenic Ministry of Education/EU
Contract Number: 379435
Researchers: E. Kolettas
Role: Coordinator (UoI); Members (16): University of Ioannina (4 members); Biomedical Research Foundation,
Budget: 600.000 €
Duration: 2012-2015

Programme: THALIS (GenAge), ESPA
Title: "Senescence and Longevity - Interaction of Genetic and Environmental factors: The role of genetic and environmental factors in aging and longevity"
Funding Source: Hellenic Ministry of Education/EU
Contract Number: 380228
Researchers: E. Kolettas
Role: Participant (IMBB-FORTH); Coordinator: G. Garinis, IMBB-FORTH, Crete
Budget: 600.000 € (Lab: 21.600 € to fund a postdoc researcher for 18 months)
Duration: 2012-2015

Programme: STATE (IKY) FELLOWSHIPS OF EXCELLENCE FOR POSTDOCTORAL RESEARCH IN GREECE - SIEMENS
Title: "Investigation of the role of IKK-mediated NF-kB signalling on the regulation of E2F-target cell cycle effectors during K-Ras-induced senescence of human fibroblasts"
Funding Source: State Scholarships Foundation
Contract Number:
Researchers: E. Kolettas
Role: PI, Supervisor of a Postdoctoral Fellow (UoI)
Budget: 39.000 €
Duration: 2014-2015

Programme: RESEARCH GRANTS IN BIOMEDICAL SCIENCES
Title: "Impact of IKKa and IKKb signalling on the control of E2F-target genes during K-Ras oncogene-mediated senescence of human fibroblasts"
Funding Source: FONDATION SANTÉ
Contract Number:
Researchers: E. Kolettas
Role: PI (IMBB-FORTH, Biomedical Research Division)
Budget: 40.000 €
Duration: 2014-2016

Programme: BIOLOGY, BIOPHOTONICS and HEALTH
Title: "Modern technological approaches & applications in the field of Biology, Photonics & Health‘ WP3.1: 'Biological-Experimental Models & Systems Biology'; ?itle: ‘The role of IKK/NF-?B signalling pathways on DNA damage and cancer"
Funding Source: General Secretariat For Research and Technology (Programmatic Agreements between Research Centres-GSRT 2015-2017, in the framework of the Hellenic Republic-Siemens agreement)
Contract Number: 5957/22-12-2016
Researchers: E. Kolettas
Role: Participant; Coordinator: IMBB-FORTH, Biomedical Research Division
Budget: 8.000 €
Duration: 2015-2017

Programme: ARCHERS
Title: "Defining canonical NF-?B regulated target genes involved in lung cancer to develop novel biomarkers and potential therapies"
Funding Source: STAVROS NIARCHOS FOUNDATION
Contract Number: Ref#SNF0031
Researchers: E. Kolettas
Role: PI (IMBB-FORTH, Biomedical Research Division)
Budget: 28.500 €
Duration: 2017-2018

Programme: BIOMEDTECH - Molecular Analysis of Biological Systems and Disease Models
Title: "Impact of canonical NF-?B signalling, ????-NF?B p65, on lung carcinogenesis"
Funding Source: General Secretariat for Research and Technology, GSRT, Greece
Contract Number: MIS 5002469
Researchers: E. Kolettas
Role: IMBB-FORTH, Biomedical Research Division; PI WP4.3
Budget: 580.000 € (Lab: 38.500 €)
Duration: 2017-2019

Programme: ARCHERS
Title: "Investigation of canonical NF-?B regulated target genes involved in lung cancer to develop novel potential therapies"
Funding Source: STAVROS NIARCHOS FOUNDATION
Contract Number:
Researchers: E. Kolettas
Role: PI (IMBB-FORTH, Biomedical Research Division)
Budget: 8.400 €
Duration: 2019-2019

Programme: Internal IMBB Bridging/Supporting Research Grant
Title: "Investigation of the mechanism of action of the canonical NF-?B signalling pathway in lung carcinogenesis"
Funding Source: IMBB-FORTH, Ioannina, Greece
Contract Number:
Researchers: E. Kolettas
Role: PI
Budget: 10.000 €
Duration: 2020-2021

Ευάγγελος Κωλέττας | Χρηματοδότηση